UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: A | B | C | D | E | H | J | K | L | M | P | R | S | T | V | W
Number of items: 63.

A

Ah- See, ML; Burcombe, RJ; Daley, FM; Richman, P; Padhani, AR; Bentzen, SM; ... Makris, A; + view all (2005) Evaluation of tunour microvessel density and pericyte coverge index following neoadjuvant chemotherapy in primary breast cancer. In: Proceedings of of ASCO. (pp. 42s - 42s).

Ah-See, M; Makris, A; Taylor, NJ; Stirling, JJ; Daley, FM; Richman, P; ... Padhani, AR; + view all (2005) Correlating breast cancer and hypoxia status with MRI features. In: Breast Cancer Research and Treatment. (pp. S205 - ?).

Ah-See, M; Padhani, AR; Taylor, NJ; Harris, AL; Burcombe, RJ; Fox, SB; ... Makris, M; + view all (2005) Lack of correlation between microvessel density & pericyte coverage index with breast cancer biposies & functional dynamic contrast-enhanced MRI-derived vascular parameters. In: Breast Cancer Research and Treatment. (pp. S74 - S75).

Ah-See, MW; Harris, AL; Burcombe, RJ; Fox, SB; Richman, PI; Daley, FM; ... Makris, A; + view all (2005) Evaluation of the effects of neoadjuvant chemotherapy on tumour microvessel density(MVD), pericyte coverage index(PCI), & vascular enodthelial growth factor(VEGF)in primary breast cancer. In: Breast Cancer Research and Treatment. (pp. S224 - ?).

Andy, S; (2005) My dad’s fight with lung cancer. Daily Express 30 - 31.

Ardeshna, KM; Kakouros, N; Qian, W; Powell, MG; Saini, N; D'Sa, S; ... Linch, DC; + view all (2005) Conventional second-line salvage chemotherapy regimens are not warranted in patients with malignant lymphomas who have progressive disease after first-line salvage therapy regimens. BRITISH JOURNAL OF HAEMATOLOGY , 130 (3) 363 - 372.

Arkenau, H; Porschen, R; (2005) Adjuvante Therapie des Kolonkarzinoms. In: Schoelmerich, J and Schmiegel, W, (eds.) Leitfaden Kolorektales Karzinom. (175 - 183). Uni-Med.-Verlag: Bremen, Germany.

B

BBC, NB; (2005) Lung cancer scientist dies at 92. UNSPECIFIED

BBC, NO; (2005) 'Freeze therapy' for lung cancers. UNSPECIFIED

BBC, NO; (2005) Thalidomide slows cancer disease. UNSPECIFIED

BBC, NO; (2005) Warning to heed lung cancer signs. UNSPECIFIED

Begent, RHJ; Kerr, P; Parkinson, H; Reddington, F; Wilkinson, JM; (2005) NCRI Informatics initiative. UNSPECIFIED

Beresford, M; Ah-See M L, T; N J, S; J J, M; A, DJA; Leach, MO; Padhani, AR; (2005) Inter-and intra-observer variability of DCE-MRI in breast cancer. In: Proceedings of the International Society of Magnetic Resonance Medicine.

Beresford, MJ; Ah-See, M; Daley, F; Richman, P; Harris, A; Makris, A; (2005) The role of the angiogenic marker, endoglin, as a predictor of response to neoadjuvant chemotherapy in primary bresat cancer. In: Breast Cancer Research and Treatment. (pp. S59 - S59).

Beresford, MJ; Ah-See, ML; Burcombe, R; Dixon, J; Ostler, P; Harrsion, M; ... A,; + view all (2005) Do pre-treatment haemaglobin levels predicct for response to neoadjuvant chemotherapy in breast cancer? In: Proc of ASCO. (pp. 80s - 80).

Beresford, MJ; Makris, A; Taylor, NJ; Stirling, JJ; Ah-See, M; d'Arcy, JA; ... Padhani, AR; + view all (2005) Observer variability in dynamic contrast-enhanced MRI when used for prediction of response to neoadjuvant chemotherapy in primary breast cancer. In: Breast Cancer Research and Treatment. (pp. S206 - ?).

Bilioni, A.; (2005) DNA binding specificities and transcriptional activity of mirror, an Iroquois transcription factor in Drosophila melanogaster. Doctoral thesis, University of London. Green open access
file

Burcombe, RJ; Makris, A; Richman, PI; Daley, FM; Noble, S; Pittam, M; ... Wilson, GD; + view all (2005) Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer. British Journal of Cancer , 92 (1) 147 - 155.

Burton, C; Smith, P; Vaughan-Hudson, G; Qian, W; Hoskin, P; Cunningham, D; ... Linch, D; + view all (2005) Comparison of CHOP versus CIOP in good prognosis younger patients with histologically aggressive non-Hodgkin lymphoma. BRITISH JOURNAL OF HAEMATOLOGY , 130 (4) 536 - 541.

C

Chang, JC; Hisenback, SG; Yee, D; Tsimelzon, A; Harrison, M; Gutierrez, CM; ... A,; + view all (2005) Gene expression profiles as predictors of response to neoadjuvant taxotere and adriamycin/cyroxan:a propsective randomized trial in breast cancers. In: Breast Cancer Research Treatment. (pp. S31 - S31).

D

Dearling, JLJ; Qureshi, U; Begent, RHJAPRB; (2005) RIT given in combination with anti-hypoxia therapy 2DG leads to loss of therapeutic efficacy. In: (Proceedings) NCRI cancer Conference Proceedings. (pp. 66 - ?).

Dearling, JLJ; Qureshi, U; Whiting, S; Boxer, G; Begent, RHJAPRB; (2005) Quantitative autoradiography revelas higher antibody uptake in peripheral intrahepatic deposits than in central deposits. In: (Proceedings) NCRI Cancer Conference Proceedings. (pp. 56 - ?).

Deborah, H; (2005) I haven’t smoked for 23 years yet now I face the serves-you-right stigma of this forgotten disease. Evening Standard 27 - 28.

E

El, EE; Dearling, J; Huhalov, A; Neri, D; Begent, RHJ; Pedley, RB; (2005) Targeting tumour vasculature in human colorectal xenografts using against the extra-domain B of fibronectin. In: (Proceedings) NCRI Cancer Conference proceedings.

H

Hoskin, PJ; (2005) Evaluation and mangement of the patient with bone metastases at presentation. In: Claude, JE and Rodolfo, CE and Lawrence, CE and Robert, CE and Gerard, S, (eds.) Textbook of Bone Metastases. (545 - 554). John Wiley & Sons

Hoskin, PJ; (2005) Overview of treatment.Cancer Pain. In: Stephen, MMK, (ed.) Wall & Melzac's Textbook of Pain. Churchill Livingstone

Hoskin, PJ; Ahmedzai, S; Muers, MF; (2005) Assessment and management of respiratory symptoms of malignant disease. In: Ahmedzai, S and Muers, MF, (eds.) Supportive care in respiratory disease. (463 - 486). Oxford University Press

Hoskin, PJ; Smith, P; Maughan, TS; Gilson, D; Vernon, C; Syndikus, I; Linch, DC; (2005) Long-term results of a randomised trial of involved field radiotherapy vs extended field radiotherapy in stage I and II Hodgkin lymphoma. CLINICAL ONCOLOGY , 17 (1) 47 - 53.

J

Jonathan, C-B; (2005) Freezing used to kill cancer cells. The Sunday Times

K

Kelly, CMA; Lee, SM; Steele, JP; (2005) Neoadjuvant chemotherapy for non-small cell lung cancer. In: Andrew, M, (ed.) Key Advances in Lung Cancer. (67 - 74). Aesculapius Medical Press: London, San Franscisco and Sydney.

Kim, J.B.; (2005) Development of a fully "humanized" xenograft model of breast cancer. Doctoral thesis, University of London. Green open access
file

Krause, M; Wohlfarth, J; Georgi, B; Pimentel, N; Dorner, D; Zips, D; ... Baumann, M; + view all (2005) Low-dose hyperradiosensitivity of human glioblastoma cell lines in vitro does not translate into improved outcome of ultrafractionated radiotherapy in vivo. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY , 81 (10) 751 - 758.

Kristeleit, R; Fong, P; Aherne, GW; de Bono, J; (2005) Histone deacetylase inhibitors: emerging anticancer therapeutic agents? Clinical lung cancer. , 7 Suppl 1

L

Lankester, K.J.; (2005) Magnetic resonance imaging and the development of vascular targeted treatments for cancer. Doctoral thesis, University of London. Green open access
file

M

Macbeth, F; Stephens, R; Hoskin, P; (2005) Radiation dose in spinal cord compression. UNSPECIFIED

Makris, A; (2005) Report on the 9th International conference on primary therapy of early breast cancer. (Breast Cancer Forum , pp. 2 - 6 ).

Makris, A; (2005) Tamoxifen and exemestane:to switch or not to switch? UNSPECIFIED

Makris, A; Hisenbeck, SG; Yee, D; Osborne, KC; Elledge, RM; Harrison, M; ... Chang, JC; + view all (2005) A prospective randomized multicenter gene expression study of docetaxel vs doxorubicin/cyclophosphamide preoperative trial in primary breast cancers. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. 14S - 14S).

P

Padhani, AR; Ah-See, ML; Taylor, NJ; Stirling, JJ; Daley, FM; Richamn, PI; ... Makris, A; + view all (2005) MRI correlates of tumour grade and hypoxia status in human breast cancer. In: Proceedings of the International Society of Magnetic Resonance Medicine.

Pedley, RB; El Emir, E; Sharma, SK; Qureshi, U; Dearling, JAB; R, HJ; (2005) Therapeutic effects of the antivascular agent combretastatin A-1 phosphate on orthotopic and subcutaneous colorectal tumours in nude mice. In: (Proceedings) Proceedings American Association for Cancer Research. (pp. 943 - ?).

Perkins, SJ; Gilbert, HE; Lee, YC; Sun, ZF; P, B; (2005) Relating small angle scattering and analytical ultracentrifugation in multidomain proteins. In: Scott, DJ and Harding, SE and Rowe, AJ, (eds.) Modern Analytical Ultracentrifugation: Techniques and Method. (291 - 319). Royal Society of Chemistry: London,UK.

Price, CA; Lingerfelt, BM; Handl, HL; Kiakos, K; Hartley, JA; Lee, M; (2005) Sequence specific recognition of DNA by tailor-made hairpin conjugates of achiral seco-cyclopropaneindoline-2-benzofurancarboxamide and pyrrole-imidazole polyamides. Bioorg Med Chem Lett , 15 (12) 3151 - 3156. 10.1016/j.bmcl.2005.04.006.

R

Rades, D; Stalpers, LJA; Veninga, T; Schulte, R; Hoskin, PJ; Alberti, W; (2005) Effectiveness and toxicity of reirradiation (Re-RT) for metastatic spinal cord compression (MSCC). STRAHLENTHERAPIE UND ONKOLOGIE , 181 (9) 595 - 600.

Rades, D; Stalpers, LJA; Veninga, T; Schulte, R; Hoskin, PJ; Obralic, N; ... Schild, SE; + view all (2005) Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression. Journal of Clinical Oncology , 23 (15) 3366 - 3376.

Ravn, P; Thornton, A; Chester, KA; Pedley, B; Davidson, B; Winslet, M; ... Meyer, T; + view all (2005) In situ selection of single chain antibodies by ex vivo perfusion of tumour-bearing human organs with phage display antibody libraries. In: (Proceedings) NCRI Cancer Conference Proceedings.

Roos, DE; Turner, SL; O'Brien, PC; Smith, JG; Spry, NA; Burmeister, BH; ... Ball, DL; + view all (2005) Randomized trial of 8 Gy in 1 versus 20 Gy in 5 fractions of radiotherapy for neuropathic pain due to bone metastases (Trans-Tasman Radiation Oncology Group, TROG 96.05). Radiotherapy & Oncology , 75 (1) 54 - 63.

Rudd, RM; Gower, NH; Spiro, G; Lee, SM; Eisen, TG; Harper, PG; ... Rankin, EM; + view all (2005) Is the tolerance to MIP Chemotherapy different Between English and Other European Populations? Journal of Clinical Oncology , 23 (25) 6270 - 6271.

S

Sainz-Pastor, N; Tolner, B; Huhalov, A; Kogelberg, H; Begent, RHJ; Chester, KA; (2005) Expression and purification of recombinant carcinoembryonic antigen frm the yeast Pichia pastoris. In: (Proceedings) NCRI Cancer Conference Proceedings.

Sainz-Pastor, N; Tolner, B; Huhalov, A; Kogelberg, H; Begent, RHJ; Chester, KA; (2005) Expression and purification of recombinant carcinoembryonic antigen from the yeast Pichia pastoris. In: (Proceedings) NCRI Cancer Conference Proceedings.

Sainz-Pastor, N; Tolner, B; Huhalov, A; Kogelberg, H; Lee, YC; Zhu, DL; ... Chester, KA; + view all (2005) Deglycosylation to obtain stable and homogeneous Pichia pastoris-expressed N-A1 domains of carcinoembryonic antigen. International Journal of Biological Macromolecules , 39 (1 -3) 141 - 150.

Sato, A; McNulty, L; Cox, K; Kim, S; Scott, A; Daniell, K; ... Lee, M; + view all (2005) A novel class of in vivo active anticancer agents: achiral seco-amino- and seco-hydroxycyclopropylbenz[e]indolone (seco-CBI) analogues of the duocarmycins and CC-1065. J Med Chem , 48 (11) 3903 - 3918. 10.1021/jm050179u.

Sharma, SK; Pedley, RB; Meyer, A; Tolner, B; Griffin, N; Green, A; ... and Chester, KA; + view all (2005) Pharmacokinetics and pharmakodynamics of a glycosylated antibody-enzyme fusion protein for ADEPT. In: (Proceedings) Proceedings American Association for Cancer Research. (pp. 984 - ?).

Short, S; Buffa, F; Koritzinsky, M; Wouters, B; Bentzen, SM; (2005) Radiation induced changes in gene expression in human glioma cells. In: Proc 6th Wolfsberg Conference on Molecular Radiation Biology/Oncology.

Short, S; C, B; F, K; M, W; B, B; S, M; (2005) UNSPECIFIED In: (Proceedings) 6th Wolfsberg Conference on Molecular Radiation Biology/Oncology.

Short, S; Hoskin, P; Wong, W; (2005) Ovulation and increased FDG uptake on PET: Potential for a false-positive result. LIPPINCOTT WILLIAMS & WILKINS, 530 WALNUT ST, PHILADELPHIA, PA 19106-3261 USA

Sujobert, P; Bardet, V; Cornillet-Lefebvre, P; Hayflick, JS; Prie, N; Verdier, F; ... Bouscary, D; + view all (2005) Essential role for the p110 delta isoform in phosphoinositide 3-kinase activation and cell proliferation in acute myeloid leukemia. BLOOD , 106 (3) 1063 - 1066. 10.1128/blood-2004-08-3225.

T

Taylor, NJ; Ah-See, ML; Stirling, JJ; d'Arcy, JA; Collins, DJ; Walker-Samuel, S; ... Padhani, AR; + view all (2005) Pre-and post-chemotherapy comparisons of calculated rBV and rBF with signal intensity drop on T2* dynamic contrast-enhanced MRI of breast cancers. In: Proceedings of the the International Society of Magnetic Resonance Medicine. (pp. 91 - 91).

Thomas, MJ; Smith, A; Head, DH; Milne, L; Nicholls, A; Pearce, W; ... Westwick, J; + view all (2005) Airway inflammation: chemokine-induced neutrophilia and the class I phosphoinositide 3-kinases. EUR J IMMUNOL , 35 (4) 1283 - 1291. 10.1002/eji.200425634.

Tolner, B; Taylorson, CJ; Kogelberg, H; Huhalov, S; Robson, L; Begent, RHJ; Chester, KA; (2005) A humanized ADEPT system using mutated human pancreatic ribonuclease. In: (Proceedings) NCRI Cancer Conference Proceedings.

V

Valle, JW; Dangoor, A; Beech, J; Lee, SM; Scarffe, JH; Swindell, R; Ranson, M; (2005) Treatment of inoperable hepatocellular carcinoma (HCC) with pegylated liposomal doxorubicin (PLD) – results of a phase II study. British Journal of Cancer , 92 (4) 628 - 630.

Vigor, K; Lee, YC; Farrell, D; Huhalov, S; Robson, L; Begent, RHJ; Chester, KA; (2005) Antibody-nanoparticle complexation for hyperthermic treatment of tumours. In: (Proceedings) NCRI Cancer Conference Proceedings.

Violet, JA; Dearling, JLJ; Marley, SJ; Green, AJ; Begent, RHJ; and, PRB; (2005) Dose fractionation reduces efficacy of radioimmunotherapy without decreasing toxicity. In: European Journal of Nuclear Medicine and Molecular Imaging. (pp. 207 - ?).

W

Westbury, C; Yarnold, J; (2005) Can a 'low risk' subgroup be identified in whom radiotherapy can safely be omitted after breast conservation surgery? In: MD, RL, (ed.) The effective management of breast cancer. (? - ?).

This list was generated on Sun May 24 03:53:04 2015 BST.